Concomitant use of pazopanib and simvastatin increases the risk of transaminase elevations in patients with cancer.
Détails
ID Serval
serval:BIB_968AFCD6236B
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Lettre (letter): communication adressée à l'éditeur.
Collection
Publications
Institution
Titre
Concomitant use of pazopanib and simvastatin increases the risk of transaminase elevations in patients with cancer.
Périodique
Annals of Oncology
ISSN
1569-8041 (Electronic)
ISSN-L
0923-7534
Statut éditorial
Publié
Date de publication
2012
Volume
23
Numéro
9
Pages
2470-2471
Langue
anglais
Notes
Publication types: Letter ; Research Support, Non-U.S. Gov't
Mots-clé
ATP-Binding Cassette Transporters/genetics, Alanine Transaminase/blood, Anticholesteremic Agents/adverse effects, Anticholesteremic Agents/pharmacology, Antineoplastic Agents/adverse effects, Antineoplastic Agents/pharmacology, Clinical Trials as Topic, Drug Interactions, Drug-Induced Liver Injury/epidemiology, Drug-Induced Liver Injury/genetics, Humans, Hypercholesterolemia/blood, Hypercholesterolemia/drug therapy, Incidence, Neoplasm Proteins/genetics, Neoplasms/blood, Neoplasms/drug therapy, Polymorphism, Single Nucleotide, Pyrimidines/adverse effects, Pyrimidines/pharmacology, Reference Values, Simvastatin/adverse effects, Simvastatin/pharmacology, Sulfonamides/adverse effects, Sulfonamides/pharmacology
Pubmed
Web of science
Open Access
Oui
Création de la notice
10/01/2013 12:23
Dernière modification de la notice
20/08/2019 15:58